Vy. Alakhov et al., HYPERSENSITIZATION OF MULTIDRUG-RESISTANT HUMAN OVARIAN-CARCINOMA CELLS BY PLURONIC P85 BLOCK-COPOLYMER, Bioconjugate chemistry, 7(2), 1996, pp. 209-216
The chemosensitizing effects of Pluronic P85 block copolymer were stud
ied using two human ovarian carcinoma sublines: the glycoprotein P (P-
gp) multidrug resistant (MDR) SKVLB cells and non-MDR SKOV3 cells. The
dramatic increase (up to 700 times) in the daunorubicin cytotoxic act
ivity was observed in the presence of 0.01% (22 mu M) to 1% (2.2 mM) c
opolymer in the case of SKVLB cells. By contrast, the copolymer induce
d a less than 3-fold increase in the drug activity in SKOV3 cells. As
a result, the MDR subline demonstrated much higher response (''hyperse
nsitivity'') to-the daunorubicin/Pluronic compared to that of the non-
MDR cells. The copolymer increased the cytotoxic effects of other MDR
type drugs (doxorubicin, epirubicin, vinblastine, and mitomycin C) by
a factor of 20-1000 and non-MDR type drugs (methotrexate and cisplatin
) by a factor of 2-5.5. The daunorubicin influx in the cytoplasm and n
uclei of SKVLB cells was also increased in the presence of the copolym
er, while in SKOV3 cells, it remained practically unchanged. However,
the hypersensitization of the MDR cells by the copolymer could not be
merely explained by the P-gp modulation. Therefore, the possible role
of the copolymer in inhibition of non-P-gp drug resistance is hypothes
ized, which may also explain the sensitization of MDR cells with respe
ct to non-MDR type drugs as well as sensitization of parental cells. T
he concentration dependence of the IC50 in MDR cells indicates that ju
st the copolymer unimers are responsible for the hypersensitization ef
fect. The results obtained suggest that Pluronic P85 can be used as a
delivery system to enhance the activity of antineoplastic agents again
st MDR tumors.